| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1026839530 |
| P356 | DOI | 10.1038/301611A0 |
| P698 | PubMed publication ID | 6402708 |
| P2093 | author name string | J F Kearney | |
| R J Bradley | |||
| D S Dwyer | |||
| C K Urquhart | |||
| P2860 | cites work | Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits | Q36355014 |
| Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus | Q36998426 | ||
| Induction of anti-idiotypic antibodies by immunisation with syngeneic spleen cells educated with acetylcholine receptor | Q39494560 | ||
| Monoclonal antibodies against defined determinants of acetylcholine receptor | Q39572617 | ||
| Idiotypic cross-reactivity of human and murine phosphorylcholine-binding immunoglobulins | Q39693724 | ||
| Biology of myasthenia gravis | Q40285163 | ||
| Monoclonal antibodies against purified nicotinic acetylcholine receptor | Q41723686 | ||
| Production of human hybridomas secreting antibodies to measles virus | Q42800318 | ||
| Naturally occurring autologous anti-idiotypic antibodies. Participation in immune complex formation in selective IgA deficiency | Q42936081 | ||
| Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors | Q46803307 | ||
| Monoclonal anti-acetylcholine receptor antibodies can cause experimental myasthenia | Q71310685 | ||
| Interaction of human antibody and murine monoclonal antibody with muscle acetylcholine receptor | Q72036719 | ||
| Thymic myogenesis, T-lymphocytes and the pathogenesis of myasthenia gravis | Q72107053 | ||
| Regulatory circuits and antibody responses | Q72606204 | ||
| P433 | issue | 5901 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myasthenia gravis | Q8285 |
| antibody | Q79460 | ||
| P304 | page(s) | 611-614 | |
| P577 | publication date | 1983-02-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients | |
| P478 | volume | 301 |
| Q67687877 | A human monoclonal IgG reactive with a private idiotope of a monoclonal IgM with autoantibody activity against myelin-associated glycoprotein |
| Q42637961 | A role for self-recognizing T cells in the regulation of antibody-forming and cell-mediated cytotoxic responses in the mouse |
| Q84007875 | Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity |
| Q42800265 | Alteration of the humoral immune response against muscle acetylcholine receptor by timed administration of α(1 → 3)dextran |
| Q48238262 | Anti-acetylcholine antibodies and the pathogenesis of myasthenia gravis |
| Q54239352 | Anti-acetylcholine receptor idiotypes in myasthenia gravis analysed by rabbit anti-sera. |
| Q38696969 | Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses |
| Q39639905 | Anti-idiotypes and autoimmune disease. |
| Q68812323 | Anti-idiotypes to anti-Lolp I (Rye) antibodies in allergic and non-allergic individuals. Influence of immunotherapy |
| Q40079960 | Anti-idiotypic antibodies as probes of cell surface receptors |
| Q74529894 | Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects |
| Q68802137 | Anti-idiotypic antibodies to anti-acetylcholine receptor antibody: characterization by ELISA and immunoprecipitation assays |
| Q54385391 | Anti-idiotypic antibodies, acetylcholine receptor antibodies and disturbed neuromuscular function in healthy relatives to patients with myasthenia gravis. |
| Q54145966 | Anti-idiotypic antibody against anti-DNA in sera of laboratory personnel exposed to lupus sera or nucleic acids. |
| Q34182775 | Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse |
| Q36985746 | Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitis. |
| Q33332866 | Antiidiotype antibody against platelet anti-GPIIIa contributes to the regulation of thrombocytopenia in HIV-1-ITP patients |
| Q35172221 | Autoantibodies to factor VIII. |
| Q38620446 | Autoimmunity and the kidney |
| Q34281885 | Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. |
| Q34561291 | Binding specificity of antiidiotypic autoantibodies to anti-DNA antibodies in humans |
| Q72448759 | Central immune system, the self and autoimmunity |
| Q69963810 | Characterization of the spontaneous autoimmune (anti-erythrocyte) response in NZB mice using a pathogenic monoclonal autoantibody and its anti-idiotype |
| Q34392902 | Circulating antibodies against human colonic extract enriched with a 40 kDa protein in patients with ulcerative colitis |
| Q37482636 | Comparison of three assays for the detection of GAD65Ab-specific anti-idiotypic antibodies |
| Q68999327 | Cross-reactive variable-region associated epitopes of human IgG1 lambda paraprotein detected by a monoclonal antibody panel |
| Q40540320 | Cryptic antiphospholipid autoantibodies and serum co-inhibitors |
| Q36354028 | DNA receptor dysfunction in systemic lupus erythematosus and kindred disorders. Induction by anti-DNA antibodies, antihistone antibodies, and antireceptor antibodies |
| Q40153644 | Demonstration and immunochemical characterization of natural, autologous anti-idiotypic antibodies throughout the course of experimental syphilis |
| Q69030299 | Demonstration of idiotypes expressed on basophil-bound IgE antibodies by using anti-idiotype-induced histamine release in grass pollen-allergic patients |
| Q68858964 | Detection of auto-anti-idiotypic antibodies to Lol p I (rye I) IgE antibodies in human sera by the use of murine idiotypes: levels in atopic and non-atopic subjects and effects of immunotherapy |
| Q72585773 | Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease |
| Q38219241 | Etiologic factors and pathogenetic aspects of organ-specific autoimmune diseases. Essential role of autoreactive T cells and lymphokine network in the activation of effector systems responsible for tissue lesions |
| Q68575943 | Evidence for a role of anti-idiotypic antibodies in the induction of remission in Graves' disease |
| Q41227397 | Experimental autoimmune uveoretinitis: idiotypic regulation and disease suppression |
| Q34549069 | Familial systemic lupus erythematosus. Presence of a cross-reactive idiotype in healthy family members |
| Q38162097 | From Jenner to Jerne: towards idiotype vaccines |
| Q38519682 | Functional and molecular studies of V genes expressed in autoantibodies |
| Q68091760 | Heterogeneity of anti-idiotypic antibodies to anti-DNA antibodies in humans |
| Q41673148 | Human autoantibodies to lamin B receptor are also anti-idiotypic to certain anti-lamin B antibodies |
| Q68091319 | Human immune response to allergens of house dust mite, Dermatophagoides pteronyssinus. IV. Occurrence of natural autologous anti-idiotypic antibodies |
| Q34245072 | Human monoclonal antibodies. |
| Q40204757 | Human monoclonal antibodies: methods of production and some aspects of their application in oncology |
| Q38182086 | Humoral pathogenesis of myasthenia gravis |
| Q35161081 | IVIG--mechanisms of action. |
| Q72384349 | Idiotype expression in rheumatoid synovial plasma cells |
| Q68812475 | Idiotype-directed interactions during ontogeny play a major role in the establishment of the adult B cell repertoire |
| Q33561061 | Idiotypes and anti-idiotypes: what are they trying to tell us? |
| Q39592364 | Idiotypes and autoimmunity |
| Q36708986 | Idiotypic Cascades Associated with the CD4-HIV gpl20 Interaction: Principles for Idiotype-Based Vaccines |
| Q36352904 | Idiotypic network connectivity and a possible cause of myasthenia gravis |
| Q72571900 | Immune status of anti-HBc positive individuals |
| Q39509900 | Immunopathogenesis and treatment of myasthenia gravis |
| Q44527655 | Infectious mononucleosis late in life |
| Q37187943 | Interfaces of the yeast killer phenomenon |
| Q33374816 | Internal-image anti-idiotype HIV-1gp120 antibody in human immunodeficiency virus 1 (HIV-1)-seropositive individuals with thrombocytopenia |
| Q34004178 | Intravenous immunoglobulin in autoimmune and inflammatory dermatoses. A review of proposed mechanisms of action and therapeutic applications |
| Q34544013 | Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis |
| Q35838787 | Management of early inflammatory arthritis. Intervention with immunomodulatory agents: new pharmacological developments |
| Q93537362 | Myasthenia gravis |
| Q72571905 | Myasthenia gravis and the anti-idiotype theory of autoimmunity |
| Q69872112 | Naturally occurring serum antiidiotypic antibody against antiliver-specific membrane lipoprotein in patients with hepatitis |
| Q39591098 | New concepts in autoimmunity |
| Q37397795 | Nucleic acid sequence of an internal image-bearing monoclonal anti-idiotype and its comparison to the sequence of the external antigen |
| Q39831056 | Phenotypic and functional analysis of lymphocytes in myasthenia gravis |
| Q35762291 | Possible therapeutic vaccines for canine myasthenia gravis: implications for the human disease and associated fatigue |
| Q33651010 | Predictable recovery from myasthenia gravis crisis with plasma exchange: thirty-six cases and review of current management |
| Q36550689 | Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor |
| Q30839172 | Production and characterization of human monoclonal anti-idiotype antibodies to anti-dsDNA antibodies |
| Q63977874 | Production and characterization of mouse monoclonal antibodies to allergenic epitopes on LolpI (Rye I) |
| Q37656095 | Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes |
| Q38696958 | Regulation of autoantibodies in inflammatory demyelinating polyneuropathy: spontaneous and therapeutic |
| Q45149123 | Regulation of retinal autoimmunity via the idiotypic network |
| Q67710715 | Relationship between naturally occurring human antibodies to casein and autologous antiidiotypic antibodies: implications for the network theory |
| Q26745015 | Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease |
| Q33349841 | Role of antiidiotypic antibodies on the clinical course of idiopathic thrombocytopenic purpura. |
| Q40922525 | Selective elimination of anti-DNA antibody-producing cells by antiidiotypic antibody conjugated with neocarzinostatin |
| Q58393545 | Self-reactive antibodies (natural autoantibodies) in healthy individuals |
| Q34538779 | Shared idiotypes and restricted immunoglobulin variable region heavy chain genes characterize murine autoantibodies of various specificities |
| Q34629461 | Single-cell analysis reveals isotype-specific autoreactive B cell repertoires in Sjögren's syndrome |
| Q39290249 | Specificities of autoantibodies in autoimmune receptor diseases |
| Q45845791 | Stimulation of clones specific for dsDNA or idiotypes of anti-dsDNA as a consequence of BK virus inoculation |
| Q42039825 | Superimposed glomerular immune complexes in anti-glomerular basement membrane disease |
| Q68836851 | Suppression of anti-DNA antibody production in MRL mice by treatment with anti-idiotypic antibodies |
| Q36348878 | T cell hybrids that express a VH idiotope-related determinant on a glycoprotein distinct from H-2, Thy-1, and Lyt-1 molecules |
| Q39499138 | The idiotype-antiidiotype network in human autoimmunity |
| Q37218062 | The immunopathogenesis of myasthenia gravis |
| Q36535592 | The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes |
| Q41021996 | The major rheumatoid factor cross-reactive idiotype in rheumatic disease |
| Q34260183 | Therapeutic treatment of New Zealand mouse disease by a limited number of anti-idiotypic antibodies conjugated with neocarzinostatin |
| Q74431931 | Time course of IgM antibodies which block anti-myelin basic protein IgG antibodies associated with development of experimental autoimmune encephalomyelitis in rabbits |
| Q68234443 | Unexpected cross-reactivity between myosin and a main immunogenic region (MIR) of the acetylcholine receptor by antisera obtained from myasthenia gravis patients |
| Q34931975 | Unravelling the pathogenesis of myasthenia gravis |
| Q34433041 | Yeast killer systems |
| Q73085297 | [Immunomodulatory effects of intravenous immunoglobulins in autoimmune diseases] |
| Q80953233 | [Immunomodulatory effects of intravenous immunoglobulins] |
Search more.